nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Temsirolimus—kidney cancer	0.104	0.22	CbGbCtD
Nimodipine—CYP3A4—Everolimus—kidney cancer	0.0602	0.127	CbGbCtD
Nimodipine—CYP3A4—Temsirolimus—kidney cancer	0.0407	0.0859	CbGbCtD
Nimodipine—CYP3A5—Erlotinib—kidney cancer	0.0391	0.0826	CbGbCtD
Nimodipine—CYP3A5—Paclitaxel—kidney cancer	0.0358	0.0756	CbGbCtD
Nimodipine—CYP3A5—Sorafenib—kidney cancer	0.0318	0.0672	CbGbCtD
Nimodipine—CYP3A5—Vincristine—kidney cancer	0.0309	0.0652	CbGbCtD
Nimodipine—CYP3A5—Sunitinib—kidney cancer	0.0257	0.0544	CbGbCtD
Nimodipine—NR3C2—collecting duct of renal tubule—kidney cancer	0.0228	0.327	CbGeAlD
Nimodipine—CYP3A4—Pazopanib—kidney cancer	0.0214	0.0451	CbGbCtD
Nimodipine—CYP3A4—Erlotinib—kidney cancer	0.0152	0.0322	CbGbCtD
Nimodipine—CYP3A4—Paclitaxel—kidney cancer	0.014	0.0295	CbGbCtD
Nimodipine—CYP3A4—Sorafenib—kidney cancer	0.0124	0.0262	CbGbCtD
Nimodipine—CYP3A4—Vinblastine—kidney cancer	0.0122	0.0259	CbGbCtD
Nimodipine—CYP3A4—Vincristine—kidney cancer	0.012	0.0254	CbGbCtD
Nimodipine—NR3C2—nephron—kidney cancer	0.0102	0.145	CbGeAlD
Nimodipine—CYP3A4—Sunitinib—kidney cancer	0.01	0.0212	CbGbCtD
Nimodipine—CYP3A4—Doxorubicin—kidney cancer	0.00752	0.0159	CbGbCtD
Nimodipine—CYP3A4—urine—kidney cancer	0.00331	0.0473	CbGeAlD
Nimodipine—AHR—nephron tubule—kidney cancer	0.00329	0.0471	CbGeAlD
Nimodipine—AHR—cortex of kidney—kidney cancer	0.00282	0.0403	CbGeAlD
Nimodipine—AHR—cardiac atrium—kidney cancer	0.00268	0.0384	CbGeAlD
Nimodipine—CACNB2—cortex of kidney—kidney cancer	0.00256	0.0366	CbGeAlD
Nimodipine—CACNB2—cardiac atrium—kidney cancer	0.00243	0.0348	CbGeAlD
Nimodipine—NR3C2—nephron tubule—kidney cancer	0.00219	0.0314	CbGeAlD
Nimodipine—CACNA1D—cardiac atrium—kidney cancer	0.00213	0.0304	CbGeAlD
Nimodipine—NR3C2—renal system—kidney cancer	0.00199	0.0285	CbGeAlD
Nimodipine—CACNA1C—cardiac atrium—kidney cancer	0.00196	0.0281	CbGeAlD
Nimodipine—NR3C2—kidney—kidney cancer	0.00193	0.0276	CbGeAlD
Nimodipine—NR3C2—cortex of kidney—kidney cancer	0.00188	0.0269	CbGeAlD
Nimodipine—NR3C2—cardiac atrium—kidney cancer	0.00179	0.0256	CbGeAlD
Nimodipine—CYP3A5—nephron tubule—kidney cancer	0.00119	0.017	CbGeAlD
Nimodipine—CYP3A5—renal system—kidney cancer	0.00108	0.0154	CbGeAlD
Nimodipine—CYP3A5—kidney—kidney cancer	0.00104	0.0149	CbGeAlD
Nimodipine—CYP3A5—cortex of kidney—kidney cancer	0.00101	0.0145	CbGeAlD
Nimodipine—Clevidipine—BCHE—kidney cancer	0.000935	0.255	CrCbGaD
Nimodipine—CYP3A4—renal system—kidney cancer	0.000809	0.0116	CbGeAlD
Nimodipine—CYP3A4—kidney—kidney cancer	0.000782	0.0112	CbGeAlD
Nimodipine—Hypersensitivity—Temsirolimus—kidney cancer	0.000579	0.0021	CcSEcCtD
Nimodipine—Muscle spasms—Sunitinib—kidney cancer	0.000575	0.00209	CcSEcCtD
Nimodipine—Anaemia—Sorafenib—kidney cancer	0.000575	0.00209	CcSEcCtD
Nimodipine—Thrombocytopenia—Vinblastine—kidney cancer	0.000574	0.00208	CcSEcCtD
Nimodipine—Nervous system disorder—Everolimus—kidney cancer	0.000573	0.00208	CcSEcCtD
Nimodipine—Thrombocytopenia—Everolimus—kidney cancer	0.000572	0.00208	CcSEcCtD
Nimodipine—Tachycardia—Everolimus—kidney cancer	0.00057	0.00207	CcSEcCtD
Nimodipine—Hyperhidrosis—Everolimus—kidney cancer	0.000565	0.00205	CcSEcCtD
Nimodipine—Oedema—Erlotinib—kidney cancer	0.000564	0.00205	CcSEcCtD
Nimodipine—Sweating increased—Paclitaxel—kidney cancer	0.000562	0.00204	CcSEcCtD
Nimodipine—Pruritus—Temsirolimus—kidney cancer	0.000556	0.00202	CcSEcCtD
Nimodipine—Nervous system disorder—Erlotinib—kidney cancer	0.000553	0.00201	CcSEcCtD
Nimodipine—Anaemia—Sunitinib—kidney cancer	0.000553	0.00201	CcSEcCtD
Nimodipine—Thrombocytopenia—Erlotinib—kidney cancer	0.000552	0.002	CcSEcCtD
Nimodipine—Hyponatraemia—Capecitabine—kidney cancer	0.00055	0.002	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000548	0.00199	CcSEcCtD
Nimodipine—Hypotension—Everolimus—kidney cancer	0.000546	0.00198	CcSEcCtD
Nimodipine—Cardiac disorder—Vincristine—kidney cancer	0.000539	0.00196	CcSEcCtD
Nimodipine—Diarrhoea—Temsirolimus—kidney cancer	0.000538	0.00195	CcSEcCtD
Nimodipine—Hypertension—Sorafenib—kidney cancer	0.000537	0.00195	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000533	0.00193	CcSEcCtD
Nimodipine—Amlodipine—CYP1A1—kidney cancer	0.000532	0.145	CrCbGaD
Nimodipine—Myalgia—Sorafenib—kidney cancer	0.000529	0.00192	CcSEcCtD
Nimodipine—Angiopathy—Vincristine—kidney cancer	0.000527	0.00191	CcSEcCtD
Nimodipine—Pruritus—Pazopanib—kidney cancer	0.000524	0.0019	CcSEcCtD
Nimodipine—Anaemia—Dactinomycin—kidney cancer	0.000523	0.0019	CcSEcCtD
Nimodipine—Dyspnoea—Everolimus—kidney cancer	0.000521	0.00189	CcSEcCtD
Nimodipine—Dizziness—Temsirolimus—kidney cancer	0.00052	0.00189	CcSEcCtD
Nimodipine—Hypertension—Sunitinib—kidney cancer	0.000516	0.00187	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000514	0.00186	CcSEcCtD
Nimodipine—Depression—Paclitaxel—kidney cancer	0.000513	0.00186	CcSEcCtD
Nimodipine—Cardiac disorder—Gemcitabine—kidney cancer	0.000512	0.00186	CcSEcCtD
Nimodipine—Myalgia—Sunitinib—kidney cancer	0.000509	0.00185	CcSEcCtD
Nimodipine—Diarrhoea—Pazopanib—kidney cancer	0.000507	0.00184	CcSEcCtD
Nimodipine—Liver function test abnormal—Capecitabine—kidney cancer	0.000506	0.00183	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Everolimus—kidney cancer	0.000505	0.00183	CcSEcCtD
Nimodipine—Dyspnoea—Erlotinib—kidney cancer	0.000503	0.00182	CcSEcCtD
Nimodipine—Angiopathy—Gemcitabine—kidney cancer	0.0005	0.00182	CcSEcCtD
Nimodipine—Vomiting—Temsirolimus—kidney cancer	0.0005	0.00181	CcSEcCtD
Nimodipine—Immune system disorder—Gemcitabine—kidney cancer	0.000498	0.00181	CcSEcCtD
Nimodipine—Nervous system disorder—Sorafenib—kidney cancer	0.000498	0.00181	CcSEcCtD
Nimodipine—Thrombocytopenia—Sorafenib—kidney cancer	0.000497	0.0018	CcSEcCtD
Nimodipine—Rash—Temsirolimus—kidney cancer	0.000495	0.0018	CcSEcCtD
Nimodipine—Dermatitis—Temsirolimus—kidney cancer	0.000495	0.0018	CcSEcCtD
Nimodipine—Headache—Temsirolimus—kidney cancer	0.000492	0.00179	CcSEcCtD
Nimodipine—Dizziness—Pazopanib—kidney cancer	0.00049	0.00178	CcSEcCtD
Nimodipine—Oedema—Sunitinib—kidney cancer	0.000488	0.00177	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000487	0.00177	CcSEcCtD
Nimodipine—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000486	0.00176	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—kidney cancer	0.000486	0.00176	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000483	0.00175	CcSEcCtD
Nimodipine—Myalgia—Dactinomycin—kidney cancer	0.000482	0.00175	CcSEcCtD
Nimodipine—Nervous system disorder—Sunitinib—kidney cancer	0.000479	0.00174	CcSEcCtD
Nimodipine—Thrombocytopenia—Sunitinib—kidney cancer	0.000478	0.00173	CcSEcCtD
Nimodipine—Nifedipine—CYP1A1—kidney cancer	0.000476	0.13	CrCbGaD
Nimodipine—Vomiting—Pazopanib—kidney cancer	0.000471	0.00171	CcSEcCtD
Nimodipine—Bradycardia—Paclitaxel—kidney cancer	0.00047	0.00171	CcSEcCtD
Nimodipine—Anaemia—Vincristine—kidney cancer	0.000468	0.0017	CcSEcCtD
Nimodipine—Rash—Pazopanib—kidney cancer	0.000467	0.00169	CcSEcCtD
Nimodipine—Nausea—Temsirolimus—kidney cancer	0.000467	0.00169	CcSEcCtD
Nimodipine—Dermatitis—Pazopanib—kidney cancer	0.000466	0.00169	CcSEcCtD
Nimodipine—Headache—Pazopanib—kidney cancer	0.000464	0.00168	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000462	0.00168	CcSEcCtD
Nimodipine—Oedema—Dactinomycin—kidney cancer	0.000462	0.00168	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—kidney cancer	0.000462	0.00168	CcSEcCtD
Nimodipine—Sweating increased—Capecitabine—kidney cancer	0.000461	0.00167	CcSEcCtD
Nimodipine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000453	0.00164	CcSEcCtD
Nimodipine—Dyspnoea—Sorafenib—kidney cancer	0.000452	0.00164	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000445	0.00161	CcSEcCtD
Nimodipine—Anaemia—Gemcitabine—kidney cancer	0.000444	0.00161	CcSEcCtD
Nimodipine—Nausea—Pazopanib—kidney cancer	0.00044	0.0016	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000438	0.00159	CcSEcCtD
Nimodipine—Hypertension—Vincristine—kidney cancer	0.000437	0.00159	CcSEcCtD
Nimodipine—Dyspnoea—Sunitinib—kidney cancer	0.000435	0.00158	CcSEcCtD
Nimodipine—Hypersensitivity—Vinblastine—kidney cancer	0.000432	0.00157	CcSEcCtD
Nimodipine—Myalgia—Vincristine—kidney cancer	0.000431	0.00156	CcSEcCtD
Nimodipine—Hypersensitivity—Everolimus—kidney cancer	0.000431	0.00156	CcSEcCtD
Nimodipine—Cardiac disorder—Paclitaxel—kidney cancer	0.000428	0.00155	CcSEcCtD
Nimodipine—Flushing—Paclitaxel—kidney cancer	0.000428	0.00155	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000421	0.00153	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000421	0.00153	CcSEcCtD
Nimodipine—Depression—Capecitabine—kidney cancer	0.000421	0.00153	CcSEcCtD
Nimodipine—Angiopathy—Paclitaxel—kidney cancer	0.000419	0.00152	CcSEcCtD
Nimodipine—Immune system disorder—Paclitaxel—kidney cancer	0.000417	0.00151	CcSEcCtD
Nimodipine—Hypertension—Gemcitabine—kidney cancer	0.000414	0.0015	CcSEcCtD
Nimodipine—Pruritus—Everolimus—kidney cancer	0.000414	0.0015	CcSEcCtD
Nimodipine—Oedema—Vincristine—kidney cancer	0.000413	0.0015	CcSEcCtD
Nimodipine—Jaundice—Capecitabine—kidney cancer	0.000411	0.00149	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—kidney cancer	0.00041	0.00149	CcSEcCtD
Nimodipine—Myalgia—Gemcitabine—kidney cancer	0.000409	0.00148	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000406	0.00147	CcSEcCtD
Nimodipine—Nervous system disorder—Vincristine—kidney cancer	0.000405	0.00147	CcSEcCtD
Nimodipine—Thrombocytopenia—Vincristine—kidney cancer	0.000404	0.00147	CcSEcCtD
Nimodipine—Diarrhoea—Vinblastine—kidney cancer	0.000401	0.00146	CcSEcCtD
Nimodipine—Diarrhoea—Everolimus—kidney cancer	0.0004	0.00145	CcSEcCtD
Nimodipine—Hyperhidrosis—Vincristine—kidney cancer	0.000399	0.00145	CcSEcCtD
Nimodipine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000399	0.00145	CcSEcCtD
Nimodipine—Pruritus—Erlotinib—kidney cancer	0.000399	0.00145	CcSEcCtD
Nimodipine—Oedema—Gemcitabine—kidney cancer	0.000392	0.00142	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000389	0.00141	CcSEcCtD
Nimodipine—Dizziness—Vinblastine—kidney cancer	0.000388	0.00141	CcSEcCtD
Nimodipine—Dizziness—Everolimus—kidney cancer	0.000387	0.0014	CcSEcCtD
Nimodipine—Muscle spasms—Paclitaxel—kidney cancer	0.000386	0.0014	CcSEcCtD
Nimodipine—Diarrhoea—Erlotinib—kidney cancer	0.000386	0.0014	CcSEcCtD
Nimodipine—Hypotension—Vincristine—kidney cancer	0.000386	0.0014	CcSEcCtD
Nimodipine—Bradycardia—Capecitabine—kidney cancer	0.000386	0.0014	CcSEcCtD
Nimodipine—Nervous system disorder—Gemcitabine—kidney cancer	0.000384	0.00139	CcSEcCtD
Nimodipine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000384	0.00139	CcSEcCtD
Nimodipine—Hepatitis—Capecitabine—kidney cancer	0.000379	0.00137	CcSEcCtD
Nimodipine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000379	0.00137	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000376	0.00137	CcSEcCtD
Nimodipine—Hypersensitivity—Sorafenib—kidney cancer	0.000374	0.00136	CcSEcCtD
Nimodipine—Vomiting—Vinblastine—kidney cancer	0.000373	0.00135	CcSEcCtD
Nimodipine—Dizziness—Erlotinib—kidney cancer	0.000373	0.00135	CcSEcCtD
Nimodipine—Vomiting—Everolimus—kidney cancer	0.000372	0.00135	CcSEcCtD
Nimodipine—Anaemia—Paclitaxel—kidney cancer	0.000371	0.00135	CcSEcCtD
Nimodipine—Rash—Everolimus—kidney cancer	0.000369	0.00134	CcSEcCtD
Nimodipine—Dermatitis—Everolimus—kidney cancer	0.000368	0.00134	CcSEcCtD
Nimodipine—Headache—Vinblastine—kidney cancer	0.000368	0.00133	CcSEcCtD
Nimodipine—Headache—Everolimus—kidney cancer	0.000366	0.00133	CcSEcCtD
Nimodipine—Hypotension—Gemcitabine—kidney cancer	0.000366	0.00133	CcSEcCtD
Nimodipine—Hypersensitivity—Sunitinib—kidney cancer	0.00036	0.00131	CcSEcCtD
Nimodipine—Pruritus—Sorafenib—kidney cancer	0.000359	0.0013	CcSEcCtD
Nimodipine—Vomiting—Erlotinib—kidney cancer	0.000359	0.0013	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000357	0.0013	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000357	0.00129	CcSEcCtD
Nimodipine—Rash—Erlotinib—kidney cancer	0.000356	0.00129	CcSEcCtD
Nimodipine—Dermatitis—Erlotinib—kidney cancer	0.000355	0.00129	CcSEcCtD
Nimodipine—Palpitations—Paclitaxel—kidney cancer	0.000355	0.00129	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—kidney cancer	0.000354	0.00129	CcSEcCtD
Nimodipine—Headache—Erlotinib—kidney cancer	0.000353	0.00128	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000353	0.00128	CcSEcCtD
Nimodipine—Cardiac disorder—Capecitabine—kidney cancer	0.000352	0.00128	CcSEcCtD
Nimodipine—Flushing—Capecitabine—kidney cancer	0.000352	0.00128	CcSEcCtD
Nimodipine—Nisoldipine—ABCB1—kidney cancer	0.000351	0.0957	CrCbGaD
Nimodipine—Dyspnoea—Gemcitabine—kidney cancer	0.000349	0.00127	CcSEcCtD
Nimodipine—Nausea—Vinblastine—kidney cancer	0.000349	0.00126	CcSEcCtD
Nimodipine—Nausea—Everolimus—kidney cancer	0.000347	0.00126	CcSEcCtD
Nimodipine—Diarrhoea—Sorafenib—kidney cancer	0.000347	0.00126	CcSEcCtD
Nimodipine—Hypertension—Paclitaxel—kidney cancer	0.000347	0.00126	CcSEcCtD
Nimodipine—Pruritus—Sunitinib—kidney cancer	0.000345	0.00125	CcSEcCtD
Nimodipine—Angiopathy—Capecitabine—kidney cancer	0.000344	0.00125	CcSEcCtD
Nimodipine—Immune system disorder—Capecitabine—kidney cancer	0.000342	0.00124	CcSEcCtD
Nimodipine—Myalgia—Paclitaxel—kidney cancer	0.000342	0.00124	CcSEcCtD
Nimodipine—Hypersensitivity—Dactinomycin—kidney cancer	0.000341	0.00124	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000338	0.00123	CcSEcCtD
Nimodipine—Dizziness—Sorafenib—kidney cancer	0.000336	0.00122	CcSEcCtD
Nimodipine—Nausea—Erlotinib—kidney cancer	0.000335	0.00122	CcSEcCtD
Nimodipine—Diarrhoea—Sunitinib—kidney cancer	0.000334	0.00121	CcSEcCtD
Nimodipine—Nitrendipine—ABCB1—kidney cancer	0.000329	0.0895	CrCbGaD
Nimodipine—Oedema—Paclitaxel—kidney cancer	0.000328	0.00119	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000326	0.00118	CcSEcCtD
Nimodipine—Dizziness—Sunitinib—kidney cancer	0.000323	0.00117	CcSEcCtD
Nimodipine—Vomiting—Sorafenib—kidney cancer	0.000323	0.00117	CcSEcCtD
Nimodipine—Nervous system disorder—Paclitaxel—kidney cancer	0.000322	0.00117	CcSEcCtD
Nimodipine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000321	0.00117	CcSEcCtD
Nimodipine—Tachycardia—Paclitaxel—kidney cancer	0.00032	0.00116	CcSEcCtD
Nimodipine—Rash—Sorafenib—kidney cancer	0.00032	0.00116	CcSEcCtD
Nimodipine—Dermatitis—Sorafenib—kidney cancer	0.00032	0.00116	CcSEcCtD
Nimodipine—Headache—Sorafenib—kidney cancer	0.000318	0.00115	CcSEcCtD
Nimodipine—Muscle spasms—Capecitabine—kidney cancer	0.000317	0.00115	CcSEcCtD
Nimodipine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000317	0.00115	CcSEcCtD
Nimodipine—Diarrhoea—Dactinomycin—kidney cancer	0.000316	0.00115	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000311	0.00113	CcSEcCtD
Nimodipine—Vomiting—Sunitinib—kidney cancer	0.00031	0.00113	CcSEcCtD
Nimodipine—Rash—Sunitinib—kidney cancer	0.000308	0.00112	CcSEcCtD
Nimodipine—Dermatitis—Sunitinib—kidney cancer	0.000308	0.00112	CcSEcCtD
Nimodipine—Hypotension—Paclitaxel—kidney cancer	0.000306	0.00111	CcSEcCtD
Nimodipine—Headache—Sunitinib—kidney cancer	0.000306	0.00111	CcSEcCtD
Nimodipine—Anaemia—Capecitabine—kidney cancer	0.000305	0.00111	CcSEcCtD
Nimodipine—Hypersensitivity—Vincristine—kidney cancer	0.000304	0.0011	CcSEcCtD
Nimodipine—Nausea—Sorafenib—kidney cancer	0.000301	0.00109	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000299	0.00108	CcSEcCtD
Nimodipine—Vomiting—Dactinomycin—kidney cancer	0.000294	0.00107	CcSEcCtD
Nimodipine—Dyspnoea—Paclitaxel—kidney cancer	0.000292	0.00106	CcSEcCtD
Nimodipine—Palpitations—Capecitabine—kidney cancer	0.000291	0.00106	CcSEcCtD
Nimodipine—Rash—Dactinomycin—kidney cancer	0.000291	0.00106	CcSEcCtD
Nimodipine—Nausea—Sunitinib—kidney cancer	0.00029	0.00105	CcSEcCtD
Nimodipine—Hypertension—Capecitabine—kidney cancer	0.000285	0.00103	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000283	0.00103	CcSEcCtD
Nimodipine—Amlodipine—ABCB1—kidney cancer	0.000283	0.0771	CrCbGaD
Nimodipine—Diarrhoea—Vincristine—kidney cancer	0.000283	0.00103	CcSEcCtD
Nimodipine—Myalgia—Capecitabine—kidney cancer	0.000281	0.00102	CcSEcCtD
Nimodipine—Pruritus—Gemcitabine—kidney cancer	0.000277	0.00101	CcSEcCtD
Nimodipine—Nausea—Dactinomycin—kidney cancer	0.000275	0.000996	CcSEcCtD
Nimodipine—Dizziness—Vincristine—kidney cancer	0.000273	0.000991	CcSEcCtD
Nimodipine—Oedema—Capecitabine—kidney cancer	0.000269	0.000977	CcSEcCtD
Nimodipine—Diarrhoea—Gemcitabine—kidney cancer	0.000268	0.000973	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—kidney cancer	0.000265	0.000962	CcSEcCtD
Nimodipine—Nervous system disorder—Capecitabine—kidney cancer	0.000264	0.000958	CcSEcCtD
Nimodipine—Thrombocytopenia—Capecitabine—kidney cancer	0.000264	0.000956	CcSEcCtD
Nimodipine—Tachycardia—Capecitabine—kidney cancer	0.000263	0.000953	CcSEcCtD
Nimodipine—Vomiting—Vincristine—kidney cancer	0.000263	0.000953	CcSEcCtD
Nimodipine—Felodipine—ABCB1—kidney cancer	0.000262	0.0713	CrCbGaD
Nimodipine—Rash—Vincristine—kidney cancer	0.00026	0.000945	CcSEcCtD
Nimodipine—Hyperhidrosis—Capecitabine—kidney cancer	0.00026	0.000944	CcSEcCtD
Nimodipine—Dermatitis—Vincristine—kidney cancer	0.00026	0.000944	CcSEcCtD
Nimodipine—Headache—Vincristine—kidney cancer	0.000259	0.000939	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000257	0.000934	CcSEcCtD
Nimodipine—Nifedipine—ABCB1—kidney cancer	0.000253	0.0689	CrCbGaD
Nimodipine—Hypotension—Capecitabine—kidney cancer	0.000252	0.000913	CcSEcCtD
Nimodipine—Vomiting—Gemcitabine—kidney cancer	0.000249	0.000904	CcSEcCtD
Nimodipine—Nicardipine—ABCB1—kidney cancer	0.000249	0.0679	CrCbGaD
Nimodipine—Bradycardia—Doxorubicin—kidney cancer	0.000249	0.000902	CcSEcCtD
Nimodipine—Rash—Gemcitabine—kidney cancer	0.000247	0.000896	CcSEcCtD
Nimodipine—Dermatitis—Gemcitabine—kidney cancer	0.000247	0.000895	CcSEcCtD
Nimodipine—Headache—Gemcitabine—kidney cancer	0.000245	0.000891	CcSEcCtD
Nimodipine—Nausea—Vincristine—kidney cancer	0.000245	0.00089	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000245	0.00089	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—kidney cancer	0.000244	0.000886	CcSEcCtD
Nimodipine—Hypersensitivity—Paclitaxel—kidney cancer	0.000242	0.000877	CcSEcCtD
Nimodipine—Dyspnoea—Capecitabine—kidney cancer	0.00024	0.000871	CcSEcCtD
Nimodipine—Nausea—Gemcitabine—kidney cancer	0.000233	0.000844	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000232	0.000843	CcSEcCtD
Nimodipine—Pruritus—Paclitaxel—kidney cancer	0.000232	0.000842	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—kidney cancer	0.000227	0.000822	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—kidney cancer	0.000227	0.000822	CcSEcCtD
Nimodipine—Diarrhoea—Paclitaxel—kidney cancer	0.000224	0.000814	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—kidney cancer	0.000222	0.000804	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—kidney cancer	0.000221	0.0008	CcSEcCtD
Nimodipine—Dizziness—Paclitaxel—kidney cancer	0.000217	0.000787	CcSEcCtD
Nimodipine—Vomiting—Paclitaxel—kidney cancer	0.000209	0.000757	CcSEcCtD
Nimodipine—Rash—Paclitaxel—kidney cancer	0.000207	0.00075	CcSEcCtD
Nimodipine—Dermatitis—Paclitaxel—kidney cancer	0.000207	0.00075	CcSEcCtD
Nimodipine—Headache—Paclitaxel—kidney cancer	0.000205	0.000746	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—kidney cancer	0.000204	0.000742	CcSEcCtD
Nimodipine—Hypersensitivity—Capecitabine—kidney cancer	0.000198	0.00072	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—kidney cancer	0.000196	0.000713	CcSEcCtD
Nimodipine—Nausea—Paclitaxel—kidney cancer	0.000195	0.000707	CcSEcCtD
Nimodipine—Pruritus—Capecitabine—kidney cancer	0.00019	0.000691	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—kidney cancer	0.000188	0.000682	CcSEcCtD
Nimodipine—Diarrhoea—Capecitabine—kidney cancer	0.000184	0.000668	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—kidney cancer	0.000184	0.000666	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—kidney cancer	0.000181	0.000657	CcSEcCtD
Nimodipine—Dizziness—Capecitabine—kidney cancer	0.000178	0.000646	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—kidney cancer	0.000173	0.00063	CcSEcCtD
Nimodipine—Vomiting—Capecitabine—kidney cancer	0.000171	0.000621	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—kidney cancer	0.00017	0.000617	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—kidney cancer	0.00017	0.000616	CcSEcCtD
Nimodipine—Rash—Capecitabine—kidney cancer	0.00017	0.000616	CcSEcCtD
Nimodipine—Dermatitis—Capecitabine—kidney cancer	0.00017	0.000615	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—kidney cancer	0.000169	0.000614	CcSEcCtD
Nimodipine—Headache—Capecitabine—kidney cancer	0.000169	0.000612	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000168	0.000609	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—kidney cancer	0.000162	0.000588	CcSEcCtD
Nimodipine—Nausea—Capecitabine—kidney cancer	0.00016	0.00058	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000158	0.000574	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—kidney cancer	0.000155	0.000561	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00015	0.000544	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—kidney cancer	0.000128	0.000464	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—kidney cancer	0.000123	0.000445	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—kidney cancer	0.000119	0.000431	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—kidney cancer	0.000115	0.000416	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—kidney cancer	0.00011	0.0004	CcSEcCtD
Nimodipine—Rash—Doxorubicin—kidney cancer	0.000109	0.000397	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—kidney cancer	0.000109	0.000397	CcSEcCtD
Nimodipine—Headache—Doxorubicin—kidney cancer	0.000109	0.000394	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—kidney cancer	0.000103	0.000374	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—RELA—kidney cancer	7.76e-05	0.000437	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—RAF1—kidney cancer	7.73e-05	0.000435	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MET—kidney cancer	7.73e-05	0.000435	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MET—kidney cancer	7.72e-05	0.000435	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	7.72e-05	0.000434	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ERBB2—kidney cancer	7.71e-05	0.000434	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MAPK1—kidney cancer	7.7e-05	0.000433	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—kidney cancer	7.64e-05	0.00043	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ST3GAL2—kidney cancer	7.6e-05	0.000427	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MAPK1—kidney cancer	7.49e-05	0.000421	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—BCHE—kidney cancer	7.48e-05	0.000421	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALDH1A1—kidney cancer	7.43e-05	0.000418	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SLC5A5—kidney cancer	7.39e-05	0.000416	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.36e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CA9—kidney cancer	7.27e-05	0.000409	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KRAS—kidney cancer	7.27e-05	0.000409	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.27e-05	0.000409	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MAPK3—kidney cancer	7.22e-05	0.000406	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTM1—kidney cancer	7.19e-05	0.000405	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SLC2A1—kidney cancer	7.13e-05	0.000401	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PGK1—kidney cancer	7.12e-05	0.000401	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC5A3—kidney cancer	7.12e-05	0.000401	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	7.1e-05	0.000399	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—kidney cancer	7.08e-05	0.000398	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—LDHB—kidney cancer	6.98e-05	0.000393	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CTNNB1—kidney cancer	6.93e-05	0.00039	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.92e-05	0.000389	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CA9—kidney cancer	6.89e-05	0.000388	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MAPK1—kidney cancer	6.87e-05	0.000387	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—RAF1—kidney cancer	6.86e-05	0.000386	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	6.82e-05	0.000384	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—kidney cancer	6.79e-05	0.000382	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KDR—kidney cancer	6.77e-05	0.000381	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CTNNB1—kidney cancer	6.75e-05	0.00038	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	6.73e-05	0.000378	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CDKN2B—kidney cancer	6.66e-05	0.000374	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MET—kidney cancer	6.62e-05	0.000373	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—RAF1—kidney cancer	6.49e-05	0.000365	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—kidney cancer	6.49e-05	0.000365	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—kidney cancer	6.43e-05	0.000362	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KDR—kidney cancer	6.41e-05	0.000361	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MET—kidney cancer	6.27e-05	0.000353	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CRABP1—kidney cancer	6.19e-05	0.000348	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—kidney cancer	6.11e-05	0.000343	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—kidney cancer	6.1e-05	0.000343	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA9—kidney cancer	6.05e-05	0.000341	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACY1—kidney cancer	6e-05	0.000338	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.97e-05	0.000336	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTP1—kidney cancer	5.95e-05	0.000335	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—kidney cancer	5.94e-05	0.000334	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CRABP1—kidney cancer	5.86e-05	0.00033	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MAPK3—kidney cancer	5.78e-05	0.000325	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MAPK3—kidney cancer	5.77e-05	0.000324	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ITPR2—kidney cancer	5.75e-05	0.000324	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RAF1—kidney cancer	5.71e-05	0.000321	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—RAF1—kidney cancer	5.71e-05	0.000321	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RELA—kidney cancer	5.68e-05	0.00032	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—kidney cancer	5.65e-05	0.000318	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—kidney cancer	5.65e-05	0.000318	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KDR—kidney cancer	5.63e-05	0.000317	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ABCB1—kidney cancer	5.63e-05	0.000317	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MAPK3—kidney cancer	5.62e-05	0.000316	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—kidney cancer	5.51e-05	0.00031	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MAPK1—kidney cancer	5.5e-05	0.000309	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.49e-05	0.000309	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MAPK1—kidney cancer	5.49e-05	0.000309	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTM1—kidney cancer	5.47e-05	0.000308	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ITPR2—kidney cancer	5.45e-05	0.000306	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—kidney cancer	5.36e-05	0.000301	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MAPK1—kidney cancer	5.35e-05	0.000301	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—MAPK1—kidney cancer	5.3e-05	0.000298	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5.25e-05	0.000295	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTT1—kidney cancer	5.24e-05	0.000295	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ACHE—kidney cancer	5.24e-05	0.000295	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—kidney cancer	5.23e-05	0.000294	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—kidney cancer	5.19e-05	0.000292	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1A1—kidney cancer	5.18e-05	0.000292	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—kidney cancer	5.18e-05	0.000292	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CRABP1—kidney cancer	5.15e-05	0.00029	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PDHB—kidney cancer	5.1e-05	0.000287	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—POMC—kidney cancer	5.08e-05	0.000286	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—kidney cancer	5.05e-05	0.000284	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—kidney cancer	4.97e-05	0.000279	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ACHE—kidney cancer	4.97e-05	0.000279	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SCARB1—kidney cancer	4.96e-05	0.000279	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—kidney cancer	4.95e-05	0.000278	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK3—kidney cancer	4.94e-05	0.000278	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—kidney cancer	4.94e-05	0.000278	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.92e-05	0.000277	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS1—kidney cancer	4.91e-05	0.000276	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RAF1—kidney cancer	4.89e-05	0.000275	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RELA—kidney cancer	4.87e-05	0.000274	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—kidney cancer	4.84e-05	0.000272	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSMD7—kidney cancer	4.82e-05	0.000271	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CCBL1—kidney cancer	4.8e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ITPR2—kidney cancer	4.78e-05	0.000269	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK1—kidney cancer	4.7e-05	0.000265	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SCARB1—kidney cancer	4.7e-05	0.000264	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK3—kidney cancer	4.68e-05	0.000263	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS1—kidney cancer	4.65e-05	0.000262	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RAF1—kidney cancer	4.63e-05	0.000261	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RELA—kidney cancer	4.61e-05	0.00026	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—kidney cancer	4.59e-05	0.000258	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—BCHE—kidney cancer	4.57e-05	0.000257	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSMD7—kidney cancer	4.56e-05	0.000257	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC5A5—kidney cancer	4.51e-05	0.000254	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK1—kidney cancer	4.45e-05	0.000251	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.45e-05	0.00025	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—kidney cancer	4.44e-05	0.00025	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—kidney cancer	4.36e-05	0.000245	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ACHE—kidney cancer	4.36e-05	0.000245	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC2A1—kidney cancer	4.36e-05	0.000245	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—kidney cancer	4.35e-05	0.000245	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—kidney cancer	4.35e-05	0.000245	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—BCHE—kidney cancer	4.33e-05	0.000243	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC5A5—kidney cancer	4.27e-05	0.00024	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—kidney cancer	4.24e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—kidney cancer	4.21e-05	0.000237	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPAT—kidney cancer	4.16e-05	0.000234	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GLIPR1—kidney cancer	4.16e-05	0.000234	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SCARB1—kidney cancer	4.13e-05	0.000232	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC2A1—kidney cancer	4.13e-05	0.000232	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK3—kidney cancer	4.12e-05	0.000232	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK3—kidney cancer	4.11e-05	0.000231	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS1—kidney cancer	4.09e-05	0.00023	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RAF1—kidney cancer	4.07e-05	0.000229	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RELA—kidney cancer	4.05e-05	0.000228	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—kidney cancer	4.03e-05	0.000227	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—kidney cancer	4.01e-05	0.000226	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSMD7—kidney cancer	4.01e-05	0.000226	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK1—kidney cancer	3.92e-05	0.00022	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK1—kidney cancer	3.91e-05	0.00022	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FH—kidney cancer	3.87e-05	0.000217	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APRT—kidney cancer	3.87e-05	0.000217	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—POMC—kidney cancer	3.86e-05	0.000217	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—BCHE—kidney cancer	3.8e-05	0.000214	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC5A5—kidney cancer	3.75e-05	0.000211	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—kidney cancer	3.73e-05	0.00021	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—kidney cancer	3.7e-05	0.000208	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—kidney cancer	3.7e-05	0.000208	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.64e-05	0.000205	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—kidney cancer	3.63e-05	0.000205	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPC3—kidney cancer	3.63e-05	0.000204	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC2A1—kidney cancer	3.63e-05	0.000204	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.59e-05	0.000202	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA2—kidney cancer	3.54e-05	0.000199	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—kidney cancer	3.53e-05	0.000199	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK3—kidney cancer	3.53e-05	0.000198	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—kidney cancer	3.53e-05	0.000198	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALAD—kidney cancer	3.45e-05	0.000194	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—kidney cancer	3.44e-05	0.000194	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCB1—kidney cancer	3.44e-05	0.000194	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ST3GAL2—kidney cancer	3.36e-05	0.000189	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK1—kidney cancer	3.36e-05	0.000189	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.34e-05	0.000188	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK3—kidney cancer	3.34e-05	0.000188	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—kidney cancer	3.34e-05	0.000188	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.3e-05	0.000186	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDH1A1—kidney cancer	3.29e-05	0.000185	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCB1—kidney cancer	3.26e-05	0.000183	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK1—kidney cancer	3.18e-05	0.000179	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.17e-05	0.000178	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—kidney cancer	3.17e-05	0.000178	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A1—kidney cancer	3.17e-05	0.000178	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—kidney cancer	3.16e-05	0.000178	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PGK1—kidney cancer	3.15e-05	0.000177	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A3—kidney cancer	3.15e-05	0.000177	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.13e-05	0.000176	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—kidney cancer	3.1e-05	0.000175	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LDHB—kidney cancer	3.09e-05	0.000174	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—kidney cancer	3.08e-05	0.000173	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—kidney cancer	3.02e-05	0.00017	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—kidney cancer	3e-05	0.000169	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—kidney cancer	3e-05	0.000169	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK3—kidney cancer	2.94e-05	0.000165	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—kidney cancer	2.86e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK1—kidney cancer	2.79e-05	0.000157	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACY1—kidney cancer	2.79e-05	0.000157	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—kidney cancer	2.78e-05	0.000156	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—kidney cancer	2.69e-05	0.000151	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA9—kidney cancer	2.68e-05	0.000151	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK3—kidney cancer	2.65e-05	0.000149	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—kidney cancer	2.64e-05	0.000148	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—kidney cancer	2.63e-05	0.000148	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—kidney cancer	2.58e-05	0.000145	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PDHB—kidney cancer	2.37e-05	0.000133	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—POMC—kidney cancer	2.36e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—POMC—kidney cancer	2.36e-05	0.000133	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CRABP1—kidney cancer	2.28e-05	0.000128	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—POMC—kidney cancer	2.24e-05	0.000126	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CCBL1—kidney cancer	2.23e-05	0.000125	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ITPR2—kidney cancer	2.12e-05	0.000119	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—POMC—kidney cancer	1.96e-05	0.000111	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.93e-05	0.000109	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPAT—kidney cancer	1.93e-05	0.000109	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—kidney cancer	1.93e-05	0.000109	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACHE—kidney cancer	1.93e-05	0.000109	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—kidney cancer	1.9e-05	0.000107	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—kidney cancer	1.88e-05	0.000106	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SCARB1—kidney cancer	1.83e-05	0.000103	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS1—kidney cancer	1.81e-05	0.000102	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APRT—kidney cancer	1.8e-05	0.000101	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FH—kidney cancer	1.8e-05	0.000101	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—kidney cancer	1.78e-05	0.0001	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSMD7—kidney cancer	1.77e-05	9.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPC3—kidney cancer	1.69e-05	9.51e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BCHE—kidney cancer	1.68e-05	9.47e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.66e-05	9.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA2—kidney cancer	1.64e-05	9.25e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—kidney cancer	1.64e-05	9.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.61e-05	9.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALAD—kidney cancer	1.6e-05	9.01e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—kidney cancer	1.57e-05	8.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.56e-05	8.8e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—kidney cancer	1.56e-05	8.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.53e-05	8.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PGK1—kidney cancer	1.47e-05	8.24e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.47e-05	8.24e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LDHB—kidney cancer	1.44e-05	8.08e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—kidney cancer	1.37e-05	7.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—kidney cancer	1.34e-05	7.53e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—kidney cancer	1.27e-05	7.13e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA9—kidney cancer	1.25e-05	7.01e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—kidney cancer	1.23e-05	6.92e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.17e-05	6.56e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—kidney cancer	1.16e-05	6.52e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—kidney cancer	1.1e-05	6.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.06e-05	5.96e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ITPR2—kidney cancer	9.85e-06	5.54e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—kidney cancer	9.64e-06	5.42e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACHE—kidney cancer	8.98e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—kidney cancer	8.98e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—POMC—kidney cancer	8.7e-06	4.89e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SCARB1—kidney cancer	8.5e-06	4.78e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS1—kidney cancer	8.41e-06	4.73e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSMD7—kidney cancer	8.25e-06	4.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BCHE—kidney cancer	7.82e-06	4.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.73e-06	4.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.46e-06	4.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—kidney cancer	6.94e-06	3.9e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—kidney cancer	6.22e-06	3.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—kidney cancer	6.05e-06	3.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—kidney cancer	5.89e-06	3.31e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—kidney cancer	5.72e-06	3.22e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.42e-06	3.05e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.27e-06	2.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—POMC—kidney cancer	4.04e-06	2.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—kidney cancer	3.22e-06	1.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—kidney cancer	2.81e-06	1.58e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.98e-06	1.12e-05	CbGpPWpGaD
